Ab Science
Clinical trials sponsored by Ab Science, explained in plain language.
-
New hope for tough leukemia: daily infusion drug enters human trials
Disease control Recruiting nowThis study tests a new drug called AB8939 in people whose acute myeloid leukemia (AML) has returned or not responded to prior treatments. The main goal is to find a safe dose and see if the drug can shrink or control the cancer. About 78 adults will receive daily infusions, and r…
Phase: PHASE1, PHASE2 • Sponsor: AB Science • Aim: Disease control
Last updated May 26, 2026 06:44 UTC
-
Promising ALS drug combo enters final testing phase
Disease control Recruiting nowThis Phase 3 trial tests whether adding masitinib to standard riluzole treatment can slow ALS progression better than riluzole alone. About 495 adults with ALS will receive either the combination or a placebo. The study measures changes in physical function, quality of life, and …
Phase: PHASE3 • Sponsor: AB Science • Aim: Disease control
Last updated May 22, 2026 14:02 UTC